199. Sarrah Strimel Bentley (Advocate, Speaker, Breast Cancer Survivor and Mom)
In this episode of the Interlude podcast, I sit down with Sarrah Strimel Bentley. Sarrah was a former Broadway performer and yoga instructor when she was diagnosed with breast cancer at the age of 38 in 2020. She underwent surgery, chemotherapy, radiation, and fertility preservation before making the decision to build her family through surrogacy…
198. Kathy Myers (Long-term breast cancer survivor who found community through dragon boat racing)
In this episode of the Interlude podcast, I speak with Kathy Myers, a long-term breast cancer survivor whose story takes us from a surprise diagnosis to a powerful, community-centered life after treatment. We recorded this conversation on Kathy’s 67th birthday, which was really meaningful. Kathy was diagnosed back in 2002 when her doctor felt a…
197. GnRH Agonists (Lupron/Zoladex) for Ovarian Function Suppression in Premenopausal Hormone Receptor Positive Breast Cancer: Monthly vs Every 3 Months?
Ovarian function suppression (OFS) is a key part of treatment for many premenopausal patients with hormone receptor–positive breast cancer, and is combined with tamoxifen or an aromatase inhibitor. OFS can be achieved surgically by removing the ovaries or medically with GnRH agonists such as Lupron or Zoladex. At the 2026 ASCO Annual Meeting, a meta-analysis…